{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:54:28Z","timestamp":1792886068907,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["NUHSRO\/2021\/081\/NUS Med\/07\/MARVELS"],"award-info":[{"award-number":["NUHSRO\/2021\/081\/NUS Med\/07\/MARVELS"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["TA24jan-0006"],"award-info":[{"award-number":["TA24jan-0006"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["RLMOE100201900000001"],"award-info":[{"award-number":["RLMOE100201900000001"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001695","name":"Japan Science and Technology Corporation","doi-asserted-by":"publisher","award":["JPMJPR23R3"],"award-info":[{"award-number":["JPMJPR23R3"]}],"id":[{"id":"10.13039\/501100001695","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04852-6","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:45:24Z","timestamp":1776249924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanisms underlying immunodynamics of layered defenses elicited by mRNA vaccination in children"],"prefix":"10.1186","volume":"24","author":[{"given":"Yiyu","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoong Kai","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon Kiat","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciszek","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson N. X.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina J. X.","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui\u2019En","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette P.","family":"Shek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Huiwen","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjia","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"1","key":"4852_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07418-y","volume":"22","author":"P Ssentongo","year":"2022","unstructured":"Ssentongo P, Ssentongo AE, Voleti N, Groff D, Sun A, Ba DM, et al. Sars-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2022;22(1):439. https:\/\/doi.org\/10.1186\/s12879-022-07418-y.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"4852_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S2213-2600(23)00015-2","volume":"11","author":"N Wu","year":"2023","unstructured":"Wu N, Joyal-Desmarais K, Ribeiro PAB, Vieira AM, Stojanovic J, Sanuade C, et al. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir Med. 2023;11(5):439\u201352. https:\/\/doi.org\/10.1016\/S2213-2600(23)00015-2.","journal-title":"Lancet Respir Med"},{"key":"4852_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.873596","volume":"10","author":"K Rahmani","year":"2022","unstructured":"Rahmani K, Shavaleh R, Forouhi M, Disfani HF, Kamandi M, Oskooi RK, et al. The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: a systematic review and meta-analysis. Front Public Health. 2022;10:873596. https:\/\/doi.org\/10.3389\/fpubh.2022.873596.","journal-title":"Front Public Health"},{"issue":"4","key":"4852_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/jamapediatrics.2022.6243","volume":"177","author":"A Watanabe","year":"2023","unstructured":"Watanabe A, Kani R, Iwagami M, Takagi H, Yasuhara J, Kuno T. Assessment of efficacy and safety of mRNA COVID-19 vaccines in children aged 5 to 11 years: a systematic review and meta-analysis. JAMA Pediatr. 2023;177(4):384\u201394. https:\/\/doi.org\/10.1001\/jamapediatrics.2022.6243.","journal-title":"JAMA Pediatr"},{"issue":"12","key":"4852_CR5","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","volume":"385","author":"N Barda","year":"2021","unstructured":"Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385(12):1078\u201390. https:\/\/doi.org\/10.1056\/NEJMoa2110475.","journal-title":"N Engl J Med"},{"issue":"1","key":"4852_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47745-z","volume":"15","author":"E Copland","year":"2024","unstructured":"Copland E, Patone M, Saatci D, Handunnetthi L, Hirst J, Hunt DPJ, et al. Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England. Nat Commun. 2024;15(1):3822. https:\/\/doi.org\/10.1038\/s41467-024-47745-z.","journal-title":"Nat Commun"},{"issue":"1","key":"4852_CR7","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1093\/infdis\/jiae329","volume":"231","author":"J Ananworanich","year":"2025","unstructured":"Ananworanich J, Lee IT, Ensz D, Carmona L, Schaefers K, Avanesov A, et al. Safety and immunogenicity of mRNA-1010, an investigational seasonal influenza vaccine, in healthy adults: final results from a phase 1\/2 randomized trial. J Infect Dis. 2025;231(1):e113\u201322. https:\/\/doi.org\/10.1093\/infdis\/jiae329.","journal-title":"J Infect Dis"},{"issue":"2","key":"4852_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/infdis\/jiad593","volume":"230","author":"X Hu","year":"2024","unstructured":"Hu X, Karthigeyan KP, Herbek S, Valencia SM, Jenks JA, Webster H, et al. Human cytomegalovirus mRNA-1647 vaccine candidate elicits potent and broad neutralization and higher antibody-dependent cellular cytotoxicity responses than the gB\/MF59 vaccine. J Infect Dis. 2024;230(2):455\u201366. https:\/\/doi.org\/10.1093\/infdis\/jiad593.","journal-title":"J Infect Dis"},{"issue":"24","key":"4852_CR9","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","volume":"389","author":"E Wilson","year":"2023","unstructured":"Wilson E, Goswami J, Baqui Abdullah H, Doreski Pablo A, Perez-Marc G, Zaman K, et al. Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults. N Engl J Med. 2023;389(24):2233\u201344. https:\/\/doi.org\/10.1056\/NEJMoa2307079.","journal-title":"N Engl J Med"},{"issue":"6572","key":"4852_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm0829","volume":"374","author":"RR Goel","year":"2021","unstructured":"Goel RR, Painter MM, Apostolidis SA, Mathew D, Meng W, Rosenfeld AM, et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science. 2021;374(6572):abm0829. https:\/\/doi.org\/10.1126\/science.abm0829.","journal-title":"Science"},{"issue":"7904","key":"4852_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-04527-1","volume":"604","author":"W Kim","year":"2022","unstructured":"Kim W, Zhou JQ, Horvath SC, Schmitz AJ, Sturtz AJ, Lei T, et al. Germinal centre-driven maturation of B cell response to mRNA vaccination. Nature. 2022;604(7904):141\u20135. https:\/\/doi.org\/10.1038\/s41586-022-04527-1.","journal-title":"Nature"},{"issue":"11","key":"4852_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100793","volume":"3","author":"JME Lim","year":"2022","unstructured":"Lim JME, Hang SK, Hariharaputran S, Chia A, Tan N, Lee ES, et al. A comparative characterization of SARS-CoV-2-specific T\u00a0cells induced by mRNA or inactive virus COVID-19 vaccines. Cell Rep Med. 2022;3(11):100793. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100793.","journal-title":"Cell Rep Med"},{"issue":"10","key":"4852_CR13","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/s41590-023-01613-y","volume":"24","author":"MM Painter","year":"2023","unstructured":"Painter MM, Johnston TS, Lundgreen KA, Santos JJS, Qin JS, Goel RR, et al. Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection. Nat Immunol. 2023;24(10):1711\u201324. https:\/\/doi.org\/10.1038\/s41590-023-01613-y.","journal-title":"Nat Immunol"},{"issue":"6","key":"4852_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cell.2022.01.029","volume":"185","author":"V Naranbhai","year":"2022","unstructured":"Naranbhai V, Nathan A, Kaseke C, Berrios C, Khatri A, Choi S, et al. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals. Cell. 2022;185(6):1041-1051.e1046. https:\/\/doi.org\/10.1016\/j.cell.2022.01.029.","journal-title":"Cell"},{"issue":"10","key":"4852_CR15","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.immuni.2022.08.008","volume":"55","author":"A Bertoletti","year":"2022","unstructured":"Bertoletti A, Le Bert N, Tan AT. SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic. Immunity. 2022;55(10):1764\u201378. https:\/\/doi.org\/10.1016\/j.immuni.2022.08.008.","journal-title":"Immunity"},{"issue":"1","key":"4852_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/imr.13089","volume":"310","author":"A Sette","year":"2022","unstructured":"Sette A, Crotty S. Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines. Immunol Rev. 2022;310(1):27\u201346. https:\/\/doi.org\/10.1111\/imr.13089.","journal-title":"Immunol Rev"},{"issue":"5","key":"4852_CR17","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41591-024-02962-3","volume":"30","author":"Y Zhong","year":"2024","unstructured":"Zhong Y, Kang AYH, Tay CJX, Li HE, Elyana N, Tan CW, et al. Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children. Nat Med. 2024;30(5):1373\u201383. https:\/\/doi.org\/10.1038\/s41591-024-02962-3.","journal-title":"Nat Med"},{"issue":"1","key":"4852_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41590-020-00826-9","volume":"22","author":"SP Weisberg","year":"2021","unstructured":"Weisberg SP, Connors TJ, Zhu Y, Baldwin MR, Lin WH, Wontakal S, et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol. 2021;22(1):25\u201331. https:\/\/doi.org\/10.1038\/s41590-020-00826-9.","journal-title":"Nat Immunol"},{"issue":"1","key":"4852_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41590-021-01089-8","volume":"23","author":"AC Dowell","year":"2022","unstructured":"Dowell AC, Butler MS, Jinks E, Tut G, Lancaster T, Sylla P, et al. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nat Immunol. 2022;23(1):40\u20139. https:\/\/doi.org\/10.1038\/s41590-021-01089-8.","journal-title":"Nat Immunol"},{"issue":"23","key":"4852_CR20","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1056\/NEJMc2103916","volume":"384","author":"N Doria-Rose","year":"2021","unstructured":"Doria-Rose N, Suthar MS, Makowski M, O\u2019Connell S, McDermott AB, Flach B, et al. Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19. N Engl J Med. 2021;384(23):2259\u201361. https:\/\/doi.org\/10.1056\/NEJMc2103916.","journal-title":"N Engl J Med"},{"issue":"9","key":"4852_CR21","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S2213-2600(21)00220-4","volume":"9","author":"Y Lustig","year":"2021","unstructured":"Lustig Y, Sapir E, Regev-Yochay G, Cohen C, Fluss R, Olmer L, et al. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lancet Respir Med. 2021;9(9):999\u20131009. https:\/\/doi.org\/10.1016\/S2213-2600(21)00220-4.","journal-title":"Lancet Respir Med"},{"issue":"24","key":"4852_CR22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114583","volume":"385","author":"EG Levin","year":"2021","unstructured":"Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, et al. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N Engl J Med. 2021;385(24):e84. https:\/\/doi.org\/10.1056\/NEJMoa2114583.","journal-title":"N Engl J Med"},{"issue":"9","key":"4852_CR23","doi-asserted-by":"publisher","first-page":"e2231778","DOI":"10.1001\/jamanetworkopen.2022.31778","volume":"5","author":"M Gilboa","year":"2022","unstructured":"Gilboa M, Regev-Yochay G, Mandelboim M, Indenbaum V, Asraf K, Fluss R, et al. Durability of immune response after COVID-19 booster vaccination and association with COVID-19 Omicron infection. JAMA Netw Open. 2022;5(9):e2231778\u2013e2231778. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.31778.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4852_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.13091","volume":"310","author":"D Goldblatt","year":"2022","unstructured":"Goldblatt D, Alter G, Crotty S, Plotkin SA. Correlates of protection against SARS-CoV-2 infection and COVID-19 disease. Immunol Rev. 2022;310(1):6\u201326. https:\/\/doi.org\/10.1111\/imr.13091.","journal-title":"Immunol Rev"},{"issue":"8","key":"4852_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1011282","volume":"19","author":"Q Clairon","year":"2023","unstructured":"Clairon Q, Prague M, Planas D, Bruel T, Hocqueloux L, Prazuck T, et al. Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2. PLoS Comput Biol. 2023;19(8):e1011282. https:\/\/doi.org\/10.1371\/journal.pcbi.1011282.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"4852_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00626-w","volume":"8","author":"Y Uwamino","year":"2023","unstructured":"Uwamino Y, Nagashima K, Yoshifuji A, Suga S, Nagao M, Fujisawa T, et al. Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination. NPJ Vaccines. 2023;8(1):33. https:\/\/doi.org\/10.1038\/s41541-023-00626-w.","journal-title":"NPJ Vaccines"},{"issue":"8","key":"4852_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70521","volume":"97","author":"LJ Ponce","year":"2025","unstructured":"Ponce LJ, Wang Y, Singh A, Chua HK, Chen M, Hor PX, et al. Modeling antibody kinetics post-mRNA booster vaccination and protection durations against SARS-CoV-2 infection. J Med Virol. 2025;97(8):e70521. https:\/\/doi.org\/10.1002\/jmv.70521.","journal-title":"J Med Virol"},{"issue":"816","key":"4852_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adv4214","volume":"17","author":"H Park","year":"2025","unstructured":"Park H, Nakamura N, Miyamoto S, Sato Y, Kim KS, Kitagawa K, et al. Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection. Sci Transl Med. 2025;17(816):eadv4214. https:\/\/doi.org\/10.1126\/scitranslmed.adv4214.","journal-title":"Sci Transl Med"},{"issue":"7","key":"4852_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009753","volume":"17","author":"AL Jenner","year":"2021","unstructured":"Jenner AL, Aogo RA, Alfonso S, Crowe V, Deng X, Smith AP, et al. COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes. PLoS Pathog. 2021;17(7):e1009753. https:\/\/doi.org\/10.1371\/journal.ppat.1009753.","journal-title":"PLoS Pathog"},{"key":"4852_CR30","doi-asserted-by":"publisher","unstructured":"Dogra P, Schiavone C, Wang Z, Ruiz-Ram\u00edrez J, Caserta S, Staquicini DI, et al. A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protection. JCI Insight. 2023;8(13). https:\/\/doi.org\/10.1172\/jci.insight.169860.","DOI":"10.1172\/jci.insight.169860"},{"issue":"1","key":"4852_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-00987-4","volume":"5","author":"G Montesi","year":"2025","unstructured":"Montesi G, Costagli S, Lucchesi S, Polvere J, Fiorino F, Pastore G, et al. Machine learning approaches to dissect hybrid and vaccine-induced immunity. Commun Med. 2025;5(1):282. https:\/\/doi.org\/10.1038\/s43856-025-00987-4.","journal-title":"Commun Med"},{"key":"4852_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105203","volume":"105","author":"M Qui","year":"2024","unstructured":"Qui M, Hariharaputran S, Hang SK, Zhang J, Tan CW, Chong CY, et al. T cell hybrid immunity against SARS-CoV-2 in children: a\u00a0longitudinal study. EBioMedicine. 2024;105:105203. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105203.","journal-title":"EBioMedicine"},{"issue":"1","key":"4852_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42408-x","volume":"14","author":"NK Tulsian","year":"2023","unstructured":"Tulsian NK, Palur RV, Qian X, Gu Y, D\/O Shunmuganathan B, Samsudin F, et al. Defining neutralization and allostery by antibodies against COVID-19 variants. Nat Commun. 2023;14(1):6967. https:\/\/doi.org\/10.1038\/s41467-023-42408-x.","journal-title":"Nat Commun"},{"issue":"9","key":"4852_CR34","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s41587-020-0631-z","volume":"38","author":"CW Tan","year":"2020","unstructured":"Tan CW, Chia WN, Qin X, Liu P, Chen MIC, Tiu C, et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2\u2013spike protein\u2013protein interaction. Nat Biotechnol. 2020;38(9):1073\u20138. https:\/\/doi.org\/10.1038\/s41587-020-0631-z.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"4852_CR35","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/S2666-5247(21)00025-2","volume":"2","author":"WN Chia","year":"2021","unstructured":"Chia WN, Zhu F, Ong SWX, Young BE, Fong S-W, Le Bert N, et al. Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study. Lancet Microbe. 2021;2(6):e240\u20139. https:\/\/doi.org\/10.1016\/S2666-5247(21)00025-2.","journal-title":"Lancet Microbe"},{"issue":"15","key":"4852_CR36","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJMoa2108453","volume":"385","author":"CW Tan","year":"2021","unstructured":"Tan CW, Chia WN, Young BE, Zhu F, Lim BL, Sia WR, et al. Pan-sarbecovirus neutralizing antibodies in BNT162b2-immunized SARS-CoV-1 survivors. N Engl J Med. 2021;385(15):1401\u20136. https:\/\/doi.org\/10.1056\/NEJMoa2108453.","journal-title":"N Engl J Med"},{"issue":"7851","key":"4852_CR37","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","volume":"591","author":"C Gaebler","year":"2021","unstructured":"Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639\u201344. https:\/\/doi.org\/10.1038\/s41586-021-03207-w.","journal-title":"Nature"},{"issue":"7855","key":"4852_CR38","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","volume":"592","author":"Z Wang","year":"2021","unstructured":"Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes CO, Finkin S, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021;592(7855):616\u201322. https:\/\/doi.org\/10.1038\/s41586-021-03324-6.","journal-title":"Nature"},{"issue":"5","key":"4852_CR39","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cell.2021.01.050","volume":"184","author":"A Sokal","year":"2021","unstructured":"Sokal A, Chappert P, Barba-Spaeth G, Roeser A, Fourati S, Azzaoui I, et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell. 2021;184(5):1201-1213.e1214. https:\/\/doi.org\/10.1016\/j.cell.2021.01.050.","journal-title":"Cell"},{"key":"4852_CR40","doi-asserted-by":"publisher","unstructured":"Tan AT, Lim JM, Le Bert N, Kunasegaran K, Chia A, Qui MD, et al. Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals. J Clin Invest. 2021;131(17). https:\/\/doi.org\/10.1172\/jci152379.","DOI":"10.1172\/jci152379"},{"issue":"1","key":"4852_CR41","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1038\/s41467-021-21856-3","volume":"12","author":"A Ogbe","year":"2021","unstructured":"Ogbe A, Kronsteiner B, Skelly DT, Pace M, Brown A, Adland E, et al. T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. Nat Commun. 2021;12(1):2055. https:\/\/doi.org\/10.1038\/s41467-021-21856-3.","journal-title":"Nat Commun"},{"key":"4852_CR42","doi-asserted-by":"publisher","unstructured":"Samandari T, Ongalo JB, McCarthy KD, Biegon RK, Madiega PA, Mithika A, et al. Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults. J Clin Invest. 2023;133(13). https:\/\/doi.org\/10.1172\/jci170011.","DOI":"10.1172\/jci170011"},{"issue":"7872","key":"4852_CR43","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","volume":"596","author":"PS Arunachalam","year":"2021","unstructured":"Arunachalam PS, Scott MKD, Hagan T, Li C, Feng Y, Wimmers F, et al. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature. 2021;596(7872):410\u20136. https:\/\/doi.org\/10.1038\/s41586-021-03791-x.","journal-title":"Nature"},{"issue":"1","key":"4852_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29391","volume":"96","author":"F Guo","year":"2024","unstructured":"Guo F, Adekanmbi V, Hsu CD, Polychronopoulou E, Berenson AB. One dose versus two doses of COVID-19 vaccine for the prevention of breakthrough infections among people previously infected with SARS-Cov-2. J Med Virol. 2024;96(1):e29391. https:\/\/doi.org\/10.1002\/jmv.29391.","journal-title":"J Med Virol"},{"key":"4852_CR45","doi-asserted-by":"publisher","unstructured":"Burnham KP, Anderson DR. Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach. 2nd ed. New York, NY: Springer; 2002. https:\/\/doi.org\/10.1007\/b97636.","DOI":"10.1007\/b97636"},{"issue":"11","key":"4852_CR46","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.cell.2022.04.009","volume":"185","author":"RR Goel","year":"2022","unstructured":"Goel RR, Painter MM, Lundgreen KA, Apostolidis SA, Baxter AE, Giles JR, et al. Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine. Cell. 2022;185(11):1875-1887.e1878. https:\/\/doi.org\/10.1016\/j.cell.2022.04.009.","journal-title":"Cell"},{"issue":"58","key":"4852_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abi6950","volume":"6","author":"RR Goel","year":"2021","unstructured":"Goel RR, Apostolidis SA, Painter MM, Mathew D, Pattekar A, Kuthuru O, et al. Distinct antibody and memory B cell responses in SARS-CoV-2 na\u00efve and recovered individuals after mRNA vaccination. Sci Immunol. 2021;6(58):eabi6950. https:\/\/doi.org\/10.1126\/sciimmunol.abi6950.","journal-title":"Sci Immunol"},{"issue":"6576","key":"4852_CR48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.abm3425","volume":"375","author":"PB Gilbert","year":"2022","unstructured":"Gilbert PB, Montefiori DC, McDermott AB, Fong Y, Benkeser D, Deng W, et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Science. 2022;375(6576):43\u201350. https:\/\/doi.org\/10.1126\/science.abm3425.","journal-title":"Science"},{"issue":"1","key":"4852_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35768-3","volume":"14","author":"Y Fong","year":"2023","unstructured":"Fong Y, Huang Y, Benkeser D, Carpp LN, \u00c1\u00f1ez G, Woo W, et al. Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial. Nat Commun. 2023;14(1):331. https:\/\/doi.org\/10.1038\/s41467-022-35768-3.","journal-title":"Nat Commun"},{"key":"4852_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1502598","volume":"15","author":"Y Zhong","year":"2024","unstructured":"Zhong Y, Kottaiswamy A, Ang CX, Li HE, Yap GC, Tay CJX, et al. Reduced durability of hybrid immunity to SARS-CoV-2 in immunocompromised children. Front Immunol. 2024;15:1502598. https:\/\/doi.org\/10.3389\/fimmu.2024.1502598.","journal-title":"Front Immunol"},{"issue":"7870","key":"4852_CR51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","volume":"596","author":"JS Turner","year":"2021","unstructured":"Turner JS, O\u2019Halloran JA, Kalaidina E, Kim W, Schmitz AJ, Zhou JQ, et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. 2021;596(7870):109\u201313. https:\/\/doi.org\/10.1038\/s41586-021-03738-2.","journal-title":"Nature"},{"issue":"1","key":"4852_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41577-023-00897-3","volume":"24","author":"T Inoue","year":"2024","unstructured":"Inoue T, Kurosaki T. Memory B cells. Nat Rev Immunol. 2024;24(1):5\u201317. https:\/\/doi.org\/10.1038\/s41577-023-00897-3.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4852_CR53","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41564-024-01903-7","volume":"10","author":"S Kalimuddin","year":"2025","unstructured":"Kalimuddin S, Tham CYL, Chan YFZ, Hang SK, Kunasegaran K, Chia A, et al. Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humans. Nat Microbiol. 2025;10(2):374\u201387. https:\/\/doi.org\/10.1038\/s41564-024-01903-7.","journal-title":"Nat Microbiol"},{"issue":"7821","key":"4852_CR54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","volume":"584","author":"N Le Bert","year":"2020","unstructured":"Le Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584(7821):457\u201362. https:\/\/doi.org\/10.1038\/s41586-020-2550-z.","journal-title":"Nature"},{"issue":"1","key":"4852_CR55","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.vaccine.2009.09.102","volume":"28","author":"AM Buisman","year":"2009","unstructured":"Buisman AM, de Rond CGH, \u00d6zt\u00fcrk K, ten Hulscher HI, van Binnendijk RS. Long-term presence of memory B-cells specific for different vaccine components. Vaccine. 2009;28(1):179\u201386. https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.102.","journal-title":"Vaccine"},{"issue":"7","key":"4852_CR56","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27(7):1205\u201311. https:\/\/doi.org\/10.1038\/s41591-021-01377-8.","journal-title":"Nat Med"},{"issue":"11","key":"4852_CR57","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","volume":"27","author":"S Feng","year":"2021","unstructured":"Feng S, Phillips DJ, White T, Sayal H, Aley PK, Bibi S, et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med. 2021;27(11):2032\u201340. https:\/\/doi.org\/10.1038\/s41591-021-01540-1.","journal-title":"Nat Med"},{"issue":"89","key":"4852_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adk5845","volume":"8","author":"T Weber","year":"2023","unstructured":"Weber T, D\u00e4hling S, Rose S, Affeldt P, Vanshylla K, Ullrich L, et al. Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool. Sci Immunol. 2023;8(89):eadk5845. https:\/\/doi.org\/10.1126\/sciimmunol.adk5845.","journal-title":"Sci Immunol"},{"issue":"6","key":"4852_CR59","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41577-021-00550-x","volume":"21","author":"D Cromer","year":"2021","unstructured":"Cromer D, Juno JA, Khoury D, Reynaldi A, Wheatley AK, Kent SJ, et al. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection. Nat Rev Immunol. 2021;21(6):395\u2013404. https:\/\/doi.org\/10.1038\/s41577-021-00550-x.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4852_CR60","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss P. The T cell immune response against SARS-CoV-2. Nat Immunol. 2022;23(2):186\u201393. https:\/\/doi.org\/10.1038\/s41590-021-01122-w.","journal-title":"Nat Immunol"},{"key":"4852_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1596518","author":"KM Wilding","year":"2025","unstructured":"Wilding KM, Molina-Par\u00eds C, Kubicek-Sutherland JZ, McMahon B, Perelson AS, Ribeiro RM. A consensus mathematical model of vaccine-induced antibody dynamics for multiple vaccine platforms and pathogens. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1596518.","journal-title":"Front Immunol"},{"key":"4852_CR62","doi-asserted-by":"publisher","unstructured":"Deng X, Farhang-Sardroodi S, Craig M. Predicting age-related determinants of heterogeneous outcomes to COVID-19 mRNA vaccines through mathematical modelling. medRxiv. 2025:2025.2002.2014.25322308. https:\/\/doi.org\/10.1101\/2025.02.14.25322308.","DOI":"10.1101\/2025.02.14.25322308"},{"issue":"2","key":"4852_CR63","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jinf.2023.11.006","volume":"88","author":"AN Diep","year":"2024","unstructured":"Diep AN, Schyns J, Gourzones C, Goffin E, Papadopoulos I, Moges S, et al. How do successive vaccinations and SARS-CoV-2 infections impact humoral immunity dynamics: an 18-month longitudinal study. J Infect. 2024;88(2):183\u20136. https:\/\/doi.org\/10.1016\/j.jinf.2023.11.006.","journal-title":"J Infect"},{"key":"4852_CR64","doi-asserted-by":"publisher","unstructured":"Bates TA, Leier HC, McBride SK, Schoen D, Lyski ZL, Lee DX, et al. An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants. JCI Insight. 2023;8(5). https:\/\/doi.org\/10.1172\/jci.insight.165265.","DOI":"10.1172\/jci.insight.165265"},{"issue":"76","key":"4852_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add4853","volume":"7","author":"J Tang","year":"2022","unstructured":"Tang J, Zeng C, Cox TM, Li C, Son YM, Cheon IS, et al. Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination. Sci Immunol. 2022;7(76):eadd4853. https:\/\/doi.org\/10.1126\/sciimmunol.add4853.","journal-title":"Sci Immunol"},{"issue":"14","key":"4852_CR66","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMc2209651","volume":"387","author":"S Havervall","year":"2022","unstructured":"Havervall S, Marking U, Svensson J, Greilert-Norin N, Bacchus P, Nilsson P, et al. Anti-Spike mucosal IgA protection against SARS-CoV-2 Omicron infection. N Engl J Med. 2022;387(14):1333\u20136. https:\/\/doi.org\/10.1056\/NEJMc2209651.","journal-title":"N Engl J Med"},{"issue":"2","key":"4852_CR67","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1473-3099(22)00834-9","volume":"23","author":"U Marking","year":"2023","unstructured":"Marking U, Bladh O, Havervall S, Svensson J, Greilert-Norin N, Aguilera K, et al. 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection. Lancet Infect Dis. 2023;23(2):150\u20132. https:\/\/doi.org\/10.1016\/S1473-3099(22)00834-9.","journal-title":"Lancet Infect Dis"},{"key":"4852_CR68","doi-asserted-by":"publisher","unstructured":"Orenstein WA, Offit PA, Edwards KM, Plotkin SA. Plotkin\u2019s Vaccines. 8th ed. Philadelphia, PA: Elsevier; 2023. https:\/\/doi.org\/10.1016\/C2019-0-00240-3.","DOI":"10.1016\/C2019-0-00240-3"},{"key":"4852_CR69","doi-asserted-by":"publisher","unstructured":"Payne RP, Longet S, Austin JA, Skelly DT, Dejnirattisai W, Adele S, et al. Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine. Cell. 2021;184(23):5699-5714.e5611. https:\/\/doi.org\/10.1016\/j.cell.2021.10.011.","DOI":"10.1016\/j.cell.2021.10.011"},{"key":"4852_CR70","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ijid.2023.02.017","volume":"130","author":"N Chantasrisawad","year":"2023","unstructured":"Chantasrisawad N, Techasaensiri C, Kosalaraksa P, Phongsamart W, Tangsathapornpong A, Jaru-Ampornpan P, et al. The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial. Int J Infect Dis. 2023;130:52\u20139. https:\/\/doi.org\/10.1016\/j.ijid.2023.02.017.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"4852_CR71","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41590-021-01126-6","volume":"23","author":"VG Hall","year":"2022","unstructured":"Hall VG, Ferreira VH, Wood H, Ierullo M, Majchrzak-Kita B, Manguiat K, et al. Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses. Nat Immunol. 2022;23(3):380\u20135. https:\/\/doi.org\/10.1038\/s41590-021-01126-6.","journal-title":"Nat Immunol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04852-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04852-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04852-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T23:16:15Z","timestamp":1779405375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04852-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4852"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04852-6","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the National Healthcare Group Domain Specific Review Board (DSRB) (202\/00945 and 2021\/00984); written parental consent and written participant assent (where appropriate) was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"324"}}